Safety and suitability of a direct thrombin inhibitor, dabigatran etexilate, in scleroderma-associated interstitial lung disease (SSC-ILD) patients

Authors
Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2018
This article has no abstract
Epistemonikos ID: aab9b5264c75b9b68721efd2171ab3a6d831e269
First added on: Feb 09, 2025